Inflammatory Breast Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Inflammatory Breast Cancer (IBC) Registry
Condition: Breast CancerInterventions: Other: Interview; Procedure: Blood and Tissue CollectionSponsors: M.D. Anderson Cancer Center; Susan G. Komen Breast Cancer FoundationRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2007 Category: Research Source Type: clinical trials

Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer
Condition: Neoplasms, BreastIntervention: Drug: lapatinibSponsor: GlaxoSmithKlineCompleted - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2005 Category: Research Source Type: clinical trials

Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer
Conditions: Breast Neoplasm; Neoplasm MetastasisInterventions: Drug: Monoclonal Antibody 3A1; Drug: Monoclonal Antibody 95-5-49; Drug: Monoclonal Antibody 95-6-22; Device: Baxter Isolex 3001 Stem Cell Selection System; Device: Ceprate SCSponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)Active, not recruiting - verified August 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 1999 Category: Research Source Type: clinical trials